1. Home
  2. WVE vs BXC Comparison

WVE vs BXC Comparison

Compare WVE & BXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

BUY

Current Price

$3.45

Market Cap

744.8M

Sector

Health Care

ML Signal

BUY

Logo Bluelinx Holdings Inc.

BXC

Bluelinx Holdings Inc.

HOLD

Current Price

$71.61

Market Cap

706.5M

ML Signal

HOLD

Company Overview

Basic Information
Metric
WVE
BXC
Founded
2012
2004
Country
United States
United States
Employees
N/A
1700
Industry
Biotechnology: Pharmaceutical Preparations
Wholesale Distributors
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
744.8M
706.5M
IPO Year
2015
2004

Fundamental Metrics

Financial Performance
Metric
WVE
BXC
Price
$3.45
$71.61
Analyst Decision
Strong Buy
Buy
Analyst Count
19
4
Target Price
$18.06
★ $88.33
AVG Volume (30 Days)
★ 2.9M
120.1K
Earning Date
11-09-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.62
Revenue
★ $3,704,000.00
N/A
Revenue This Year
$19.21
$5.56
Revenue Next Year
N/A
$4.54
P/E Ratio
★ N/A
$113.82
Revenue Growth
★ 149.43
N/A
52 Week Low
$3.43
$44.78
52 Week High
$21.73
$93.80

Technical Indicators

Market Signals
Indicator
WVE
BXC
Relative Strength Index (RSI) 25.92 42.34
Support Level N/A $47.84
Resistance Level $6.33 $81.73
Average True Range (ATR) 0.23 3.92
MACD -0.02 -0.60
Stochastic Oscillator 8.56 14.29

Price Performance

Historical Comparison
WVE
BXC

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Inc is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About BXC Bluelinx Holdings Inc.

BlueLinx Holdings Inc is engaged in the wholesale distribution of residential and commercial building products. Its business products are split into two categories: Structural products include items such as lumber, plywood, oriented strand board, rebar, and remesh, and Specialty products include items such as engineered wood, siding, millwork, outdoor living, specialty lumber and panels, and industrial products. The company's operations are carried out throughout the United States.

Share on Social Networks: